This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Kole Roybal, PhD
Associate Professor, Microbiology & Immunology at UCSF School of Medicine


Dr. Roybal is an Associate Professor in the Department of Microbiology and Immunology at the University of California, San Francisco. His lab has focused on the development of advanced engineered receptor systems (e.g. synNotch, SNIPRs, and CARs) that allow for the precise detection of tumors and the customization of the therapeutic response specifically at the site of disease. His mission is to engineer and distribute a comprehensive toolkit of clinically optimized molecular parts including new receptors and therapeutic signaling circuits that can be deployed in a broad range of cell-based therapeutics for diseases such as cancer and autoimmunity.

He was awarded the Sartorius and Science Magazine Prize for Regenerative Medicine and Cell Therapy in 2017, the NIH New Innovator Award in 2018, and the Cancer Research Institute STAR Award in 2022.He has also founded next-generation cell therapy companies based on his body of work including Cell Design Labs (now a Gilead company), Arsenal Bio, Dispatch Therapeutics, and Moonlight Bio.

Agenda Sessions

  • Towards the Development of Synthetic Immunity to Cancer